Recent studies from our laboratory have examined the role of the interaction between bacterial endotoxin (lipopolysaccharide, LPS), and hemoglobin in the pathogenesis of sepsis. We have demonstrated that cell-free hemoglobin enhances LPS-mediated mortality 8 and augments the tumor necrosis factor response, in vivo, to LPS. 11 In addition, LPS and hemoglobin have been shown to form stable complexes in vitro, 12 with a resultant increase in LPS biological activity as measured by Limulus amebocyte lysate activation, 12,13 peripheral Bacterial endotoxin (lipopolysaccharide) has affinity for a number of cations, including iron. Previous investigations have demonstrated that lipopolysaccharide can affect the oxidation rate of iron; heme-bound ferrous iron in hemoglobin is oxidized to ferric iron when hemoglobin binds lipopolysaccharide. In the present study, we directly examined the interaction between lipopolysaccharide and iron. Lipopolysaccharide caused a concentration-dependent increase in the rate of iron oxidation, with up to a 23-fold increase in oxidation in the presence of 200 µg/ml Escherichia coli lipopolysaccharide. This effect was seen both with several carbohydrate-rich smooth lipopolysaccharides and also with carbohydrate-poor rough lipopolysaccharide. Extensively deacylated rough lipopolysaccharide had no effect, suggesting a role of the fatty acid components of lipopolysaccharide in this process. Purified lipid A produced inconsistent results: some preparations stimulated iron oxidation and others did not. A series of sugars, starches and a preparation of purified O-chain polysaccharide (the carbohydrate portion of the lipopolysaccharide macromolecule) had no effect on the rate of iron oxidation, whereas phospholipid-enriched brain tissue extracts (similar to the lipid A component of lipopolysaccharide) stimulated oxidation. We conclude that the lipid moiety of bacterial lipopolysaccharide is responsible for the stimulation of iron oxidation. This process may contribute to the ability of lipopolysaccharide to cause oxidation of heme-bound iron in hemoglobin.
INTRODUCTION
Iron appears to play a number of diverse roles in the promulgation of bacterial infection and sepsis. Iron is an essential nutrient for bacterial proliferation, and bacteria have high affinity siderophores in order to utilize host sources of iron. It has long been hypothesized that hypoferremia, a characteristic of infections and sepsis, represents a host response to limit bacterial proliferation. 1, 2 Iron-containing hemoglobin is also a pathogenic factor in infection. Enhanced morbidity and mortality from infection has been documented in the settings of hemorrhagic peritonitis, 3, 4 hemoglobinemia secondary to hemolysis dur-ing sepsis, 5, 6 or when cell-free hemoglobin (a red blood cell substitute) is infused in the presence of sepsis. [7] [8] [9] In these conditions, it is possible that heme-derived iron may become available for bacterial growth. Alternatively, a variety of mechanisms other than providing nutrient iron may be involved in the deleterious combination of hemoglobin and infection, including inhibition by iron of leukocyte anti-bacterial activity, 4,10 depression of reticulo-endothelial cell system function, 5, 6 and enhancement of lipopolysaccharide-mediated toxicity. [7] [8] [9] blood monocyte procoagulant activity, 14 and endothelial cell procoagulant activity. 13, 15 Disaggregation of high molecular weight LPS particles was observed after hemoglobin binding, 12, 16 and a correlation between LPS disaggregation, increased solubility, and enhanced biological activity in vitro was demonstrated. 13 These in vitro consequences of the hemoglobin-LPS interaction suggest a possible mechanism for enhanced LPS-mediated morbidity and mortality in the presence of free hemoglobin.
In addition to the potential for hemoglobin to increase LPS-mediated pathology, it is also possible that LPS may augment deleterious iron-mediated processes such as free radical production or lipid peroxidation. [17] [18] [19] Previous studies from our laboratory have demonstrated that LPS-hemoglobin complex formation was associated with hemoglobin auto-oxidation and resultant production of methemoglobin. 20 Coincident with the observed hemoglobin auto-oxidation were spectral changes in the hemoglobin molecule consistent with a partial loss of heme and iron. 20 Our previous investigations did not address experimentally the possible mechanisms for this auto-oxidation, which could potentially include LPS interactions with globin and/or heme causing destabilization of the hemoglobin molecule, or direct interaction of LPS with heme iron. Cations, including iron, are known to complex naturally with LPS. 21 We reasoned that iron lost from heme in destabilized hemoglobin might become associated with the LPS in the hemoglobin-LPS complexes. In fact, our most recent studies demonstrated saturable binding of iron to LPS. 22 Thus it seemed possible that LPS binding to hemoglobin initially could result in hemoglobin destabilization and ferrous iron loss, followed by iron binding to adjacent LPS molecules. The present studies were undertaken to examine whether binding of ferrous iron to LPS could, in turn, produce the iron oxidation noted in our earlier experiments with hemoglobin. 
MATERIALS AND METHODS

Reagents
Assays of iron oxidation
Ferrous chloride was dissolved in 2 mM Tris buffer, pH 5.0 immediately prior to use. In the standard iron oxidation experiment, the ferrous chloride was prepared at 0.5 mM; the final iron concentration in the complete reaction mixture was 0.125 mM. Stock solutions of lipopolysaccharides, lipid A, polysaccharide O-chain, sugars and starches were each at 1.0 mg/ml in Tris buffer, pH 5.0; their final concentration in the complete reaction mixture ranged from 0.165-0.25 mg/ml. Lipopolysaccharide and lipid A preparations were vortexed approximately 2 min and briefly sonicated (30 s) in a water bath at room temperature prior to use. Deferoxamine was prepared in Tris at 0.5 mM; the final concentration in the complete reaction mixture was 0.125 mM. In a typical experiment, equal volumes of Tris buffer, ferrous chloride, lipopolysaccharides/lipid A or sugars, and deferoxamine were mixed in spectrophotometer cuvettes (final volumes ranged from 600-800 µl). Deferoxamine was always added last, immediately prior to t 0 absorbance measurements. In preliminary experiments, it was established that freshly prepared solutions of ferrous chloride underwent minimal auto-oxidation during the short time required for sample preparation and incubation as long as the deferoxamine, which appeared to catalyze the oxidation process, was the final addition to the mixtures. Using a multichannel pipette, six incubation samples were rapidly prepared and assayed simultaneously using a Beckman DU7400 spectrophotometer (Beckman Instruments, Fullerton, CA, USA). Oxidation reactions were conducted at room temperature for up to 120 min. Oxidation of ferrous iron to the ferric form, detected by production of ferric iron-deferoxamine complexes, was monitored at 1-min intervals at 429 nm. 23, 24 Differences in solution turbidity due to varying LPS solubility were corrected by subtracting t 0 absorbances at 429 nm for each reaction. All experiments were independently performed at least twice.
RESULTS
A variety of LPS structures were tested for their ability to alter the rate of iron oxidation. Based on the previous observations that smooth LPS, rough LPS, and purified lipid A were each capable both of inducing hemoglobin oxidation 20 and binding iron, 22 we hypothesized that each of these endotoxin structures might be able to induce iron oxidation.
Effect of LPS on iron oxidation
Oxidation of ferrous iron was measured by spectrophotometric detection of ferric iron-deferoxamine complexes. Concentration-dependent stimulation of the rate of iron oxidation was observed using a standard LPS (E. coli O26:B6 smooth LPS; Fig. 1A ). The initial rate of iron oxidation was stimulated approximately 23-fold over control at an LPS concentration of 200 µg/ml (Fig.  1B) . In the presence of LPS, essentially all of the iron in the incubation became oxidized as determined from the absorbance at 429 nm and the extinction coefficient of the Fe-deferoxamine complex (2300-2700 M -1 cm -1 ). 23, 24 Under the conditions of this experiment, LPS turbidity was minimal and did not contribute to the absorbance measurements at 429 nm. Stimulation of iron oxidation also was observed with two other commonly used endotoxins, E. coli O55:B5 smooth LPS and S. minnesota R595 rough (Re) LPS (Fig. 2) . In a separate experiment, a third smooth LPS (from P. mirabilis S1959) was similarly shown to stimulate iron oxidation (data not shown). Polymyxin B, up to a 10-fold concentration excess over LPS by weight, had no effect on E. coli O26:B6-induced iron oxidation (data not shown).
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Effect of partial LPS structures on iron oxidation
Purified lipid A from three strains of LPS (S. minnesota R595, Ps. aeruginosa PAC605, and P. mirabilis R45) was examined for an effect on the rate of iron oxidation (Fig. 3 ). Lipid A from S. minnesota R595 had a stimulatory effect, whereas the other two lipid As had no effect on the rate of iron oxidation. These discrepant results were confirmed in three independent experiments, and suggested that unknown chemical and/or physical differences between lipid A preparations were important for their interaction with iron. S. minnesota R595 lipid A formed considerably larger particles in solution (based on visual turbidity) than the other lipid A preparations, perhaps influencing its interaction with iron. Neither isolated O-chain, free of lipid A component and core saccharide, nor extensively deacylated S. minnesota R595 LPS, had any effect on iron oxidation (data not shown).
Effect of sugars and carbohydrate on iron oxidation
Although the experiments described above with rough LPS and isolated O-chain suggested that a major carbohydrate moiety was not required or sufficient for stimulation of iron oxidation, we performed additional control experiments to help support this conclusion. A variety of sugars (glucose, galactose, glucosamine, and sucrose) and starches (hydroxyethylstarch, viastarch, Starch-Waxy Maize and dextran 40) were chosen to mimic carbohydrate components of LPS (the O-chain, core saccharide, and diglucosamine component of lipid A). None of these compounds affected the rate of iron oxidation (data not shown).
Effect of lipid preparations on iron oxidation
The experiments described above failed to suggest a significant role for core and O-chain polysaccharide in increasing the rate of iron oxidation. Despite the inconsistent capability of isolated lipid A to cause oxidation, we continued to think that the property of whole LPS to oxidize iron most likely resided in the lipoidal moiety. It also has been noted previously that isolated lipid A similarly does not interact in a consistent manner with hemoglobin. 13 To further investigate this possibility, we tested the ability of other lipid-enriched particles to increase iron oxidation. Similar to LPS, rabbit brain thromboplastin and purified dog brain phosphatidylethanolamine stimulated iron oxidation compared to control ( Fig. 4) .
DISCUSSION
The present studies demonstrated that the addition of bacterial lipopolysaccharide to iron results in accelerated iron oxidation. Both the rate and extent of iron oxidation were increased in the presence of LPS. Approximately 3 times as much ferrous iron eventually became oxidized in the presence of 200 µg/ml LPS compared to that oxidized in the absence of LPS (Fig. 1A) , and the initial rate of iron oxidation could be increased by as much as 23fold at the highest LPS concentration tested (Fig. 1B) . By the end of the incubation period, essentially all of the iron in the incubation mixtures had become oxidized in the presence of LPS. Although the molar absorptivity of tripartite Fe-LPS-DFO complexes is not known, we believe that it is appropriate to use the ferrioxamine extinction coefficient in these calculations because the extremely high affinity of deferoxamine for Fe 3+ (Ka = 10 31 ) will favor complete hexadentate chelation of iron versus formation of the tripartate Fe-LPS-DFO complex. Based on our previous iron-LPS binding studies, 22 we would expect that only approximately 5% of the added iron in our incubations bound to LPS. The mechanism by which substantial iron oxidation results from only a relatively small extent of stable LPS binding is unclear, although this finding suggests that LPS serves as an initiating event. Stimulation of iron oxidation by smooth LPS, rough LPS, one of the lipid A tested, purified phosphatidyl ethanolamine, and rabbit brain thromboplastin strongly suggests that interaction of iron with the lipoidal region of LPS is the initiating event. The inability of polymyxin B to interfere with LPS-induced iron oxidation suggests that biologically active LPS is not required for this effect. The data in Figure 3 show that the lipid A component from S. minnesota is, by itself, capable of significantly accelerating iron oxidation, and previous studies have demonstrated that lipid components, presumably lipid hydroperoxides, are capable of oxidizing Fe 2+ . 25 The data illustrated in Figure 4 indicate that a component of rabbit brain homogenates is also capable of increasing Fe 2+ oxidation, but it is unknown whether lipid hydroperoxides were present in that preparation. However, since lipid hydroperoxides are formed via the peroxidation of polyunsaturated fatty acids, which are not found in lipid A, it is unlikely that lipid hydroperoxides are participating in the accelerated oxidation of Fe 2+ observed in the current experiments with LPS or lipid A.
Based on the ability of LPS to increase the rate of iron oxidation, we hypothesize that an LPS-iron interaction could similarly contribute to the oxidation of iron detected in our previous experiments with hemoglobin. 20 When LPS binds hemoglobin, there is a process of accelerated iron oxidation, including spectral changes consistent not only with oxidation to methemoglobin but also with iron and heme loss. Although we do not know the fate of released iron, both ferrous and ferric iron have been shown to be capable of binding to LPS. 22 Since our present work demonstrated acceleration of iron oxidation by LPS, we believe it likely that ferrous iron released from hemoglobin during the degradation process can then be oxidized if it binds to LPS. We postulate the following series of events: (i) LPS binds hemoglobin, at or near the heme pocket; (ii) iron interacts with nearby LPS, in part becoming oxidized to the ferric state and destabilizing the heme pocket; (iii) the destabilized heme pocket releases iron, likely as a mixture of reduced and oxidized forms; and (iv) free iron is bound to LPS, the reduced form becoming oxidized upon binding. Additional experiments will be required to determine how much iron is physically released from hemoglobin, and whether the resulting free iron is then bound to LPS as a mixture of ferrous and ferric forms, as hypothesized.
The mechanism by which LPS could enhance iron oxidation is uncertain, since many factors can influence iron oxidation. However, previous experiments from our laboratory have demonstrated that bacterial endotoxin can bind ('chelate') both Fe 2+ and Fe 3+ , and this interaction may lower the reduction potential of the Fe 3+ /Fe 2+ couple, accelerating the oxidation of iron. This interpretation is also compatible with the dose-response relationship shown in Figure 1 . Whereas the process of LPS-induced iron oxidation in hemoglobin can be directly followed spectrophotometrically, the present studies required that iron be bound to a siderophore (i.e. deferoxamine) to follow the process of oxidation. Figure 2 demonstrates that Fe 2+ is more rapidly oxidized by rough endotoxin from S. minnesota in the presence of deferoxamine than by deferoxamine alone, and Figure 3 shows the same results for S. minnesota lipid A. These data suggest that the rough endotoxin or lipid A alone are mediating this effect or that an interaction between endotoxin or lipid A and deferoxamine is producing accelerated iron oxidation. The possibility that deferoxamine is participating in the oxidation of Fe 2+ and, in the process, generating active oxidants, raises the possibility that other free radicals may be involved.
We believe that the processes of iron binding to LPS, with subsequent oxidation, may have relevance to bacterial infections. Bacterial virulence is enhanced by administration of iron, and bacteria, as well as other organisms, require iron for growth. 26 Since the solubility of iron at physiological pH is very limited, it is logical that microorganisms have evolved sophisticated mechanisms for iron sequestration. Many micro-organisms synthesize and secrete chelators that can bind iron and maintain its solubility at physiological pH. 27 However, these chelators have not been reported to associate with, or bind to, endotoxin. In addition, bacterial cell membranes have been demonstrated to have metal binding sites that serve as transmembrane redox systems, and LPS could be part of such a system. 28, 29 In essence, LPS could act as a siderophore aiding in iron acquisition. Transferrin-bound iron is in the ferric state and is delivered to cells in this oxidized form, whereas when transferrin is saturated, any additional free, soluble iron (derived from hemoglobin as a result of hemolysis or cell-free Hb transfusion) is in the ferrous state because the solubility of ferric iron at physiological pH is extremely low. Human hemoglobin uptake by bacteria has been recently demonstrated, and it was hypothesized to represent a mechanism for obtaining iron. 30 Similarly, porcine hemoglobin has been shown to bind to the surface of Actinobacillus pleuropneumoniae, and to the LPS and lipid A of this LPS; and the bacterium was able to use this bound hemoglobin as its iron source. 31 LPS may aid in oxidizing iron for effective utilization of this important metal by bacteria. This type of metal binding site would also be consistent with the dose-response relationship seen in Figure 1 . Finally, some bacteria have evolved iron-binding sites with catalytic ferroxidase activity associated with iron storage proteins. 32 This type of binding site is less compatible with the results of the current experiments because these proteins are not associated with the cell membrane.
CONCLUSIONS
In conclusion, bacterial LPS-dependent oxidation of Fe 2+ is likely to occur through a variety of mechanisms, including simple iron 'auto-oxidation' as well as free radical formation. In previous studies, we have demonstrated that the binding of iron to endotoxin decreased the biological activity of LPS and, if endotoxin undergoes free radical attack during iron binding and oxidation, perhaps its chemical structure, composition, or aggregation state is altered. Finally, an interaction between iron and the LPS in the membrane of Gram-negative bacteria may directly contribute to bacterial virulence.
